万维提示：
1、投稿方式：在线投稿。
2、官网网址：https://academic.oup.com/endo
3、投稿网址：http://www.editorialmanager.com/endocrinology/Default.aspx
4、官网邮箱：publications@endocrine.org（联系）
5、官网电话：202-971-3669（联系）
6、期刊刊期：月刊，一个月出版一期。
2021年4月29星期四
投稿须知
【官网信息】
Endocrinology Author Guidelines
Article Types
The following types of articles, including preprints from recognized repositories, will be considered for publication:
Presubmission Inquiries (Optional)
Presubmission Inquiries offer authors an alternative way to determine if a manuscript is of interest to Endocrinology before undergoing the full submission process. Presubmission Inquiries are never published and are not required prior to full manuscript submission. The submission process is fast – approximately 1 minute – and requires only a brief (250 word maximum) text explanation of the manuscript’s importance, a title, and an abstract (250 word maximum). The editors will review the Presubmission Inquiry and decide whether to encourage submission of the full manuscript for evaluation, or to discourage its submission on the basis of its described scope. Peer review is not guaranteed for manuscripts whose submission is encouraged. Authors are also welcome to initially submit their full manuscripts through the regular submission process, without submitting any Presubmission Inquiry.
Original Articles
Research Articles are original, investigative, non-clinical studies based on previously unpublished data. There are no upper or lower word/figure/table limits. All figures and tables must be original.
Brief Reports are a category of research article, not to exceed 2,400 words, for the rapid communication of original, investigative, non-clinical studies based on previously unpublished data. All figures and tables must be original.
Methods Articles
Technical Resource articles detail a significant advance in methodology in the field of endocrinology, such as a new technique or a new animal or cell model. They can present biologically significant data generated using the most current and novel approaches and technologies in genomics, proteomics, metabolomics, structural biology, high throughput screening, computational biology, and related methods, and suggest mechanistic conclusions, which may be supported by focused studies. These articles have a typical length of 2,400 words. All figures and tables must be original.
Review Articles
Mini-reviews are short reviews, ranging from 2,000 words to a maximum of 5,000 words, that are intended to reach a broad spectrum of endocrinologists. Mini-reviews should integrate the latest discoveries with the current literature, providing critical analytical interpretation of the significance of any new information described. Authors should include a brief section describing the search strategies used to obtain information for the review. If the authors choose to use previously published figures or tables, they must follow the guidelines under the Publication Fees section.
Opinion and Comment
Editorials are opinion articles by the journal's Editor-in-Chief or an Associate Editor and will typically address a timely policy matter of very high importance to endocrinologists. Editorials carry no figures or tables and have no more than eight references.
Commentaries are opinion articles invited by the Editor-in-Chief that will examine concepts and findings recently introduced into the scientific record that have exceptional interest. They are typically up to 1,000 words in length, should have no more than eight references, and have no figures or tables. Commentaries should not cite unpublished work or data.
Perspectives present a new viewpoint on policies and generally accepted principles and practices in endocrinology that warrant closer examination based on very recent newly published data. They should cite relevant literature and are typically no longer than 2,400 words, have no more than eight references, and have no figures or tables. Perspectives should not cite unpublished work or data. Perspectives are submitted by invitation from the Editor-in-Chief.
Reports and Recommendations present a summary of the proceedings and conclusions of work groups, task forces, and other collaboratives. They will be subject to peer review and must be modifiable in response to criticisms. They are typically no more than 3,600 words in length. All figures and tables must be original. If interested in submitting, contact the Editorial Office at publications@endocrine.org.
Letters to the Editor should discuss only articles published in final format in this journal, and be submitted within six months of the article’s final publication. (Concerns about Advance Articles should be be brought to the attention of the Executive Editor.) Letters must be no more than 500 words in length, have no more than eight references, and must not cite unpublished work or data. Letters will be published at the discretion of the Editor-in-Chief. Authors of accepted letters see page proofs before publication. Only changes to correct inadvertent/introduced grammar and/or spelling inaccuracies are permitted. Regular publication charges apply. No figures or tables are allowed. The title of the letter should follow the format of “Letter to the Editor: [Title of Original Article being Discussed]”. Should your title not follow this format, it will be standardized by the publisher.
Letters to the Editor Responses reply to a Letter to the Editor at no greater length than the original letter. Authors whose work is discussed in a Letter to the Editor will typically be invited to provide a response. If accepted, authors will see page proofs before publication. Only changes to correct inadvertent/introduced grammar and/or spelling inaccuracies are permitted. No figures or tables are allowed. The title of the letter should follow the format of “Response to Letter to the Editor: [Title of Original Article being Discussed]”. Should your title not follow this format, it will be standardized by the publisher.
Endocrine Society Communications
The following article types are official Endocrine Society communications:
Clinical Practice Guidelines are developed by an Endocrine Society appointed task force, are evidence based, and provide graded clinical practice recommendations. These are developed with input from Society committees and members.
Clinical Practice Guideline Meta-analyses are commissioned by the Endocrine Society to provide statistical analyses to support its Clinical Practice Guidelines.
Clinical Practice Guideline Systematic Reviews are commissioned by the Endocrine Society for its Clinical Practice Guidelines. These reviews address a defined clinical question by collecting and summarizing empirical evidence that fits pre-specified eligibility criteria.
Clinical Practice Guideline Communications are derivatives of the Endocrine Society's Clinical Practice Guidelines that supplement or comment on developments in the disease area since the time of publication of a Guideline.
Clinical Practice Guideline Updates are developed to address interim changes in prevention, diagnosis, or management in an existing Endocrine Society Clinical Practice Guideline since the time of publication of a Guideline.
Clinical Practice Guideline Alerts are focused communications in response to new developments that significantly alter recommendations in an existing Endocrine Society Clinical Practice Guideline (e.g., important new drug approval(s), important drug withdrawal(s), important new risks or harms). These address changes that impact the validity of a guideline and affect patient safety.
Policy Perspectives are based on established Society policy positions and developed by the Advocacy & Public Outreach Core Committee with input from the membership.
Research Guides are developed by an expert writing group under the direction of the Research Affairs Core Committee.
Scientific Statements are developed by an expert writing group under the direction of an Endocrine Society appointed Chair with input from Society committees and the membership.
Consensus Statements are developed by an expert writing group under the direction of an Endocrine Society appointed Chair with input from Society committees.
Position Statements are documents that reflect the Society’s position or response to an issue. They are developed in consultation with member experts and under direction of a Committee. They are vetted by a Committee or Task Force; undergo a public comment period, if appropriate; and are approved by the Society’s Board.
Use of Peer Review: All submissions are subject to external peer review as directed by the journal editors, other than (1) Endocrine Society Communications, which are reviewed by the Endocrine Society and selected outside experts, and (2) meeting abstracts, which, when published as a supplement to Journal of the Endocrine Society, have been reviewed by the Endocrine Society’s Annual Meeting Steering Committee.
Questions? Please direct any questions to publications@endocrine.org.
Publication Fees and Open Access
Publication Fees
For more information on the benefits of membership in the Endocrine Society, please visit the Member Benefits page of the Endocrine Society’s website.
The following charges apply to all Endocrinology manuscripts with an initial submission date of January 1, 2018 or later.
Page Charges
Endocrine Society members: No charge for first 8 PDF pages. Additional pages at $49 per PDF page.
Non-members: $119 per PDF page for all pages
Color Charges
Endocrine Society members: No charge
Non-members: No charge
Letter to the Editor Charge
Endocrine Society members: $99 per PDF page
Non-members: $99 per PDF page
Optional Upgrade to Open Access
Endocrinology offers the option of publishing under either a standard licence or an open access licence. Please note that some funders require open access publication as a condition of funding. If you are unsure whether you are required to publish open access, please do clarify any such requirements with your funder or institution.
Should you wish to publish your article open access, you should select your choice of open access licence in our online system after your article has been accepted for publication. You will need to pay an open access charge to publish under an open access licence.
Details of the open access licences and open access charges.
Questions about licences and charges can be sent to jnls.author.support@oup.com.
OUP has a growing number of Read and Publish agreements with institutions and consortia which provide funding for open access publishing. This means authors from participating institutions can publish open access, and the institution may pay the charge. Find out if your institution is participating.
Use of Previously Published Figures and Tables in Mini-reviews
Authors are responsible for obtaining the appropriate permissions to reproduce or adapt previously published figures or tables. Because publishers frequently hold copyright, this often applies to an author’s own materials. We strongly encourage authors to submit original figures and tables when possible instead of using previously published materials. For assistance on preparing original figures and tables, authors should consider contacting American Journal Experts.
If an author chooses to reproduce or adapt a previously published figure or table in a mini-review, the following procedure applies:
The author agrees to obtain the permissions prior to submission and is responsible for all expenses related to securing authorization to use the previously published figure or table.
The author will provide the editorial office with a copy of the permissions or copyright form with their submission files. This includes copies of articles in the public domain or that carry a CC-BY license.
The Copyright Clearance Center is often the easiest way for authors to clear permissions to reproduce or adapt any figures or tables that have been previously published. If you have any questions regarding the specifications required for permissions, please contact publications@endocrine.org
The permissions must include the following:
non-exclusive rights to reproduce the material in the specified article and journal;
print and electronic rights, preferably for use in any form or medium;
the right to use the material for the life of the work; and
world-wide English-language rights.
If the author does not finalize the required permissions, the author must either replace the reproduced or adapted content with original material or delete the content and any corresponding references to it.
The author must include a credit line for all material being reproduced or adapted in a paper. The credit line must include the source information of the original table or figure. If the copyright holder does not provide an author with a specific credit line, the author/date text citation and the words “with permission” should be used.
If material has been adapted, the words “adapted from” should be included along with the author/date citation (e.g., “Adapted from Jones 2008”).
If material has been reproduced, the words “reproduced from” should be included along with the author/date citation (e.g., “Reproduced from Jones 2008”).
The author understands that all issues related to the use of previously published figures and tables as outlined above must be resolved before the revised manuscript can be considered.
Copyright usually resides with the creator of the work—the author, artist, or other originator. However, when a work is published, the creator usually licenses the copyright to the publisher and loses control over it while the licence is in force. This means that the agreement of the author to re-use material does not constitute copyright permission. To seek permission to reproduce a published work, you must approach the rights holder, which is usually the publisher. Also note that if the work was made in the course of employment, copyright is owned by the employer unless a contract specifies otherwise.
Post-Publication Access Policies and Funder Requirements
Articles funded by the National Institutes of Health (NIH), Wellcome Trust, Howard Hughes Medical Institute (HHMI), and Canadian Institutes of Health Research (CIHR) will be submitted to PubMed Central after final issue publication and will be made freely available in 12 months.
There are additional US Government Agencies and private funders that have partnerships with the National Library of Medicine to leverage the PubMed Central infrastructure. A list of these organizations can be found at the PMC website. For specific information on how to comply with the policies of these funders, please see their websites. For information on depositing a paper in PubMed Central in compliance with a public access policy, see the PMC submission webpage.
Please note that some funders (such as the Wellcome Trust and Research Councils UK) may require publication under an Open Access license and subsequent payment of a fee. Open access costs and publication charges are authorized grant expenses for which authors can seek reimbursement from the Wellcome Trust, Research Councils UK, or funders operating under their policies. These articles will contain the following language: "This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited."
If your manuscript is accepted for publication, you will be asked at the proof stage to confirm the funding source of your paper and to agree to pay any applicable post-publication access fees.
Reimbursement: The Endocrine Society will consider requests for reimbursement of APCs from funder and institutional customers in the event that we do not materially comply with their Open Access requirements. Contact publications@endocrine.org.
Manuscript Preparation Guidelines and Checklist
Below is a checklist of the basic format requirements. For more information, see Editorial Policies. If you have any questions, contact the editorial staff at publications@endocrine.org.
Guidelines on General Preparation of Initial Submissions
Read the Editorial Policies. Note: Endocrine Society journals allow submissions from preprints: see Preprint Repositories and Prior Publication.
Format Neutral Submission: New manuscripts may be submitted format neutral, as a single Word, RTF, or PDF file with continuous line numbering. Technical formatting such as reference layout and order of components is not scrutinized for compliance at this initial stage. If the required information is present (complete title page, all author information, abstract, full text, line numbering, figures and tables, references, etc.) the manuscript will be assessed solely on its scientific merit. Note that metadata extraction will work only for manuscripts uploaded as Word files.
Submit paper in English through the Editorial Manager system.
Use a double-spaced, single-column format with 1-inch margins.
Use continuous line numbering throughout the manuscript. Manuscripts submitted without line numbers will be returned.
Paginate the entire document.
Place all tables and figures after the references and clearly label each.
Gather needed information prior to starting the submission process in Editorial Manager:
Full names, institutions, and email addresses for each author.
Submitting authors are required to provide an ORCiD when uploading a manuscript.
Appropriate funding information for each author.
Disclosure information for each author.
Original manuscript number if manuscript being submitted was previously rejected by the journal to which it is being resubmitted.
No cover letter is needed. A text block is provided during the submission process for special requests.
Appropriate figure file specifications as detailed in the Figure Guidelines have been followed.
……
